Article Details

Myeloma: VRd Plus Isatuximab Improves Outcomes | MDedge Hematology and Oncology

Retrieved on: 2024-06-11 18:36:34

Tags for this article:

Click the tags to see associated articles and topics

Myeloma: VRd Plus Isatuximab Improves Outcomes | MDedge Hematology and Oncology. View article details on hiswai:

Excerpt

The addition of an anti-CD38 monoclonal antibody to the standard first-line combination treatment significantly improved outcomes in newly ...

Article found on: www.mdedge.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up